Evidence map›Paper›PMID 20139324›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2010

Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases.

Jianjie Wang, Susan Bingaman, Virginia H Huxley

Abstract readComparative Study
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Sex, Endothelial Cell Functions, and Peripheral Artery Disease.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Review
  10. Review
  11. Matters of the heart: Cellular sex differences.Journal of molecular and cellular cardiology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Lymphatic Function and Dysfunction in the Context of Sex Differences.ACS pharmacology & translational science · 2019
    Review
  19. Endocrine treatment of aging transgender people.Reviews in endocrine & metabolic disorders · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jianjie WangDept. of Biomedical Science, Missouri State Univ., Springfield, 65897, USA. Jwang@Missouristate.edu
Susan Bingaman
Virginia H Huxley
University of Missouri · USMissouri State University · US

Funding

Vascular Biology: Exercise Training and Vascular DiseaseP01HL052490 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI LAUGHLIN, M HAROLD · 1995 to 2010
$19.3M
Microvascular Permeability and SexR01HL078816 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI HUXLEY, VIRGINIA H · 2005 to 2008
$1.4M
Sexual Dimorphism of Skeletal MuscleR21HL093068 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI HUXLEY, VIRGINIA H · 2010 to 2011
$396k
NHLBI NIH HHS P01 HL052490NHLBI NIH HHS R01 HL078816NHLBI NIH HHS R01HL078816NHLBI NIH HHS R21 HL093068
6 · The paper itself

Abstract

The importance of gonadal hormones in the regulation of vascular function has been documented. An alternate and essential contribution of the sex chromosomes to sex differences in vascular function is poorly understood. We reported previously sex differences in microvessel permeability (P(s)) responses to adenosine that were mediated by the cAMP signaling pathway (Wang J, PhD thesis, 2005; Wang J and Huxley V, Proceedings of the VIII World Congress of Microcirculation, 2007; Wang J and Huxley VH, Am J Physiol Heart Circ Physiol 291: H3094-H3105, 2006). The two cyclic nucleotides, cAMP and cGMP, central to the regulation of vascular barrier integrity, are hydrolyzed by phosphodiesterases (PDE). We hypothesized that microvascular endothelial cells (EC) would retain intrinsic and inheritable sexually dimorphic genes with respect to the PDEs modulating EC barrier function. Primary cultured microvascular EC from skeletal muscles isolated from male and female rats, respectively, were used. SRY (a sex-determining region Y gene) mRNA expression was observed exclusively in male, not female, cells. The predominant isoform among PDE1-5, present in both XY and XX EC, was PDE4. Expression mRNA levels of PDE1A (male > female) and PDE3B (male < female) were sex dependent; PDE2A, PDE4D, and PDE5A were sex independent. Barrier function, P(s), was determined from measures of albumin flux across confluent primary cultured microvessel XY and XX EC monolayers. Consistent with intact in situ microvessels, basal monolayer P(s) did not differ between XY (1.7 +/- 0.2 x 10(-6) cm/s; n = 8) and XX (1.8 +/- 0.1 x 10(-6) cm/s; n = 10) EC. Cilostazol, a PDE3 inhibitor, reduced (11%, P < 0.05) P(s) in XX, not XY, cells. These findings demonstrate the presence and maintenance of intrinsic sex-related differences in gene expression and cellular phenotype by microvascular EC in a gonadal-hormone-free environment. Furthermore, intrinsic cell-sex likely contributes significantly to sexual dimorphism in cardiovascular function.

Indexed as

Sex CharacteristicsAnimalsCells, CulturedCilostazolCyclic AMPCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 3Endothelium, VascularFemaleMaleMicrocirculationModels, AnimalMuscle, SkeletalPhosphodiesterase 3 InhibitorsPhosphodiesterase IPhosphodiesterase InhibitorsCilostazolCyclic AMPCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 3Phosphodiesterase 3 InhibitorsPhosphodiesterase IPhosphodiesterase InhibitorsRNA, MessengerTetrazoles

Identifiers

PMID20139324
PMCPMC2853420
OpenAlexW2042407150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.